FindTrial
Sign In

A Study of gargle for oral mucositis associated with cancer therapy

Effect of hangeshashinto solution on oral mucositis associated with cancer therapy - Effect of hangeshashinto solution on oral mucositis associated with cancer therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047116
Enrollment
10
Registered
2022-03-14
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant growth

Interventions

None listed

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with oral mucositis during cancer therapy at Nagasaki University Hospital

Exclusion criteria

Exclusion criteria: Patients with severe hepatic and renal dysfunction Patients with aldosteronism, myopathy, and hypokalemia Patients with allergies or other drug sensitivities pregnant women and patients who may be pregnant or nursing. Patients who have participated in other clinical studies within 4 months Other patients deemed inappropriate as research subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
Common Terminology Criteria for Adverse Events v3.0—

Countries

Japan

Contacts

Public ContactHiromi Yamashita

Nagasaki University Department of Forensic Dental Science, Unit of Social Medicine

hiyamashita@nagasaki-u.ac.jp095-819-7076

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026